Medline Slovakia Manufacturing Expansion Project Expected to Launch in 2027
2026-06-10 18:06
Favorite

en.Wedoany.com Reported - Medline International B.V. (a subsidiary of Medline Inc.) is advancing its strategic manufacturing expansion project in Partizánske, Slovakia, to strengthen the supply chain resilience and operational capabilities of this medical surgical product supplier in Europe, the Middle East, and Africa.

Located adjacent to Medline's existing facility, the new plant will significantly expand the company's manufacturing capacity to support its future growth in the European medical market. The project is progressing as planned, with production operations expected to commence in 2027.

Medline Inc. is a medical supplies manufacturer and distributor. Its dedicated Dynacor Plastics division produces medical-grade plastic products, with facilities in Mundelein, Illinois, and Laredo, Texas. The Slovakia expansion includes a new cleanroom and optimized operational processes aimed at improving efficiency, flexibility, and supply reliability for medical customers in the region. This investment reflects Medline's strategy of manufacturing products close to end users, reducing supply chain vulnerabilities, and maintaining quality standards.

Hervé Million, President of Medline Europe, Middle East, and Africa, stated that this expansion represents a significant strategic investment in the company's European manufacturing network, helping to deliver high-quality, reliable solutions to customers close to the point of demand. The project also reflects the company's confidence in the future, its commitment to operational excellence, and its dedication to the employees and communities that support its growth. The Slovakia expansion is expected to create additional jobs over time, further solidifying Medline's position as a leading medical manufacturing employer in the country. The facility will support the company's extensive product portfolio, serving hospitals, nursing homes, and medical professionals across Europe, the Middle East, and Africa.

Medline's investment in European manufacturing capacity aligns with the growing demand for resilience and localized supply chains in the healthcare industry. The company aims to improve clinical, financial, and operational outcomes for healthcare providers by combining global scale with regional insights. Chief Commercial Officer Doug Golwas noted that the company's progress over the years and its focus on serving healthcare providers across all points of care have built a vast product portfolio and one of the strongest and most resilient supply chains in the industry.

Founded in 1966, Medline distributes approximately 335,000 medical products, of which about 190,000 are under the Medline brand and approximately 70,000 are self-manufactured. Headquartered in the United States, the company employs over 45,000 people globally and operates in more than 100 countries and regions.

This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com